The minimum prevalence of CADASIL in northeast England
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
References
1.
Adib-Samii P, Brice G, Martin RJ, Markus HS. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke 2010; 41: 630– 634.
2.
Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 2004; 127: 2533– 2539.
3.
Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 2002; 12: 371– 84.
4.
Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 2005; 76: 739– 741.
5.
Markus HS, Martin RJ, Simpson MA, et al. Diagnostic strategies in CADASIL. Neurology 2002; 59: 1134– 1138.
6.
Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. CADASIL. Lancet Neurol 2009; 8: 643– 653.
7.
Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 2004; 127: 2031– 2038.
Information & Authors
Information
Published In
Copyright
Copyright © 2012 by AAN Enterprises, Inc.
Publication History
Received: May 17, 2011
Accepted: November 4, 2011
Published online: March 14, 2012
Published in print: March 27, 2012
Funding Information
Disclosure: Dr. Narayan reports no disclosures. Dr. Gorman receives research support from the UK NIHR Biomedical Research Centre for Ageing and Age-related Disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust. Dr. Kalaria serves on the editorial board of Behavioral and Brain Functions; has received speaker honoraria from Pfizer Inc; and receives research support from Alzheimer’s Research Trust. Dr. Ford serves on a scientific advisory board for Lundbeck, Inc. and Astra Zeneca; serves on the editorial advisory boards for Drugs and Ageing and the International Journal of Stroke; has received speaker honoraria from Lundbeck, Inc., Boehringer Ingelheim, and Bristol-Myers Squibb; and his spouse owns stock in GlaxoSmithKline. Dr. Chinnery serves as an Associate Editor for Brain.
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Amygdala and cognitive impairment in cerebral small vessel disease: structural, functional, and metabolic changes, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1398009
- How genetics is impacting on stroke, thrombolysis for central retinal artery occlusion, and cerebral microinfarcts, International Journal of Stroke, 19, 1, (4-6), (2024).https://doi.org/10.1177/17474930231217911
- Most common NOTCH3 mutations causing CADASIL or CADASIL-like cerebral small vessel disease: A systematic review, Cerebral Circulation - Cognition and Behavior, 6, (100227), (2024).https://doi.org/10.1016/j.cccb.2024.100227
- Monogenic causes of cerebral small vessel disease and stroke, Inherited White Matter Disorders and Their Mimics, (273-287), (2024).https://doi.org/10.1016/B978-0-323-99209-1.00018-1
- Monogenic causes of stroke, Genomic and Molecular Cardiovascular Medicine, (295-314), (2024).https://doi.org/10.1016/B978-0-12-822951-4.00018-7
- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), Stroke Genetics, (117-137), (2024).https://doi.org/10.1007/978-3-031-41777-1_6
- Update on the Epidemiology, Pathogenesis, and Biomarkers of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy, Journal of Clinical Neurology, 19, 1, (12), (2023).https://doi.org/10.3988/jcn.2023.19.1.12
- Headache and NOTCH3 Gene Variants in Patients with CADASIL, Neurology International, 15, 4, (1238-1252), (2023).https://doi.org/10.3390/neurolint15040078
- Approaching Headaches—A Guide to Differential-Diagnostic Considerations and Causal Claims, Clinical and Translational Neuroscience, 7, 3, (17), (2023).https://doi.org/10.3390/ctn7030017
- Lifelong cerebrovascular disease burden among CADASIL patients: analysis from a global health research network, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1203985
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.